Sillery, Canada

Pierre Borgeat




Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Sillery, CA (1998 - 2014)
  • Quebec, CA (2015)

Company Filing History:


Years Active: 1998-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Pierre Borgeat: Innovator in Pharmaceutical Solutions

Introduction

Pierre Borgeat, an accomplished inventor based in Sillery, Canada, has made significant contributions to the field of pharmaceutical innovations. With a total of seven patents to his name, Borgeat has focused on developing advanced therapeutic formulations, particularly in the area of viral infections.

Latest Patents

Among his latest patents is the development of a recombinant human CC10 protein for the treatment of influenza. This innovative method employs recombinant human uteroglobin, or rhCC10, to effectively reduce viral titers in lung tissues, specifically targeting influenza. The patent outlines therapeutic strategies for using rhCC10 to treat, cure, or prevent influenza infections, detailing critical dosage ranges and various administration routes, including intravenous and intranasal options. Additionally, another noteworthy invention pertains to a novel pharmaceutical formulation that stabilizes an LTB4 agent at an alkaline pH, significantly enhancing the agent's shelf life to a minimum of 24 months.

Career Highlights

Pierre Borgeat has worked with renowned companies in the pharmaceutical sector, including Virocell Inc. and LTB4 Sweden AB. His innovative work has positioned him as a key player in addressing viral infections and improving treatment methods.

Collaborations

Throughout his career, Borgeat has collaborated with notable professionals such as Jean Gosselin and Bassam Damaj. These collaborations have contributed to his success in developing groundbreaking pharmaceutical formulations.

Conclusion

Pierre Borgeat's innovations in the realm of pharmaceutical solutions underline his commitment to advancing treatments for viral infections. With numerous patents and fruitful collaborations, he continues to pave the way for new therapeutic options in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…